Empagliflozin 25 mg/d plus Pioglitazone (15/30 mg/d) Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Empagliflozin, a medication used in the management and treatment of type 2 diabetes mellitus. It is in the sodium-glucose co-transporter (SGLT-2) class of medications., Empagliflozin/Pioglitazone

Filter by location:

San Antonio, Texas1 trial

SGLT2i, Pioglitazone, and Ketone Production in T2D

Texas Diabetes Institute/UH

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.